For UK healthcare professionals only
Media partner:
Click here to access ENTRESTO® (sacubitril/valsartan) prescribing information.
ENTRESTO® (sacubitril/valsartan) is indicated in adult patients for the treatment of symptomatic chronic heart failure with reduced ejection fraction1
Adverse events reporting information can be found at the bottom of the page.
Click here to access more information about ENTRESTO®.
The landscape of heart failure (HF) care has evolved in recent years. While HF continues to pose a significant challenge to both primary and secondary care, recent developments in our understanding of the condition have led to the development of more advanced diagnostic pathways, medications and device-based interventions that can help patients to live longer with a better quality of life.2,3
In this four-part on-demand video series, our experts provide an update on the key aspects of HF care in the UK, including a comprehensive overview of the condition and its associated comorbidities, practical tips on investigation and diagnosis, an examination of pharmacological and non-pharmacological treatment options (including the role of devices), and a discussion on the role of primary care in the management of individuals with HF.
References
Patricia Campbell is Consultant Cardiologist and Heart Failure (HF) Lead in the Southern Trust in Northern Ireland. She did her cardiology training between Dublin and the Mayo Clinic, Scottsdale, and was then fortunate enough to do her training in HF under Professor Lynne Stevenson, and echocardiography research under Professor Scott Solomon in Brigham and Women’s Hospital/Harvard Medical School. Dr Campbell was Assistant Professor at the University of Calgary and the University College Dublin before returning to her hometown to take up her current post. Her published research focuses on HF haemodynamics, the right heart in HF and more recently, on optimal clinical pathways for HF patients. She sits on the board of the British Society of HF, the Clinical Advisory Board of the HF charity, ‘Pumping Marvellous’, and on the board of the Cardiovascular Disease Taskforce for Northern Ireland as well as the Irish Cardiac Society.
Jim Moore works in Gloucestershire as a GP with a special interest (GPSI) in cardiovascular medicine and is the immediate Past-President of the Primary Care Cardiovascular Society, which currently has over 3,600 members. He lectures extensively across the UK.
Dr Moore has been heavily involved in national cardiovascular disease advisory groups, guidelines and working parties. He is currently a member of the National Heart Failure Audit Expert Steering Group. Previously, he was a member of the NICE Chronic Heart Failure in Adults Guideline Committee (2016–2018) and was a board member of the British Society for Heart Failure.
Dr Moore has provided cardiovascular clinical support to local commissioning organisations for over two decades and more recently, to Cardiac Clinical Networks in South West England. He is currently Clinical Co-Lead (Primary Care) for the West of England Integrated Cardiac Clinical Network. Furthermore, he is the National Clinical Co-Lead (Primary Care) for the National Cardiac Transformation Programme, which has included working closely on NHS England initiatives, such as Managing Heart Failure @ Home, and more recently chaired a group that developed the National NHS England guidance for virtual ward care for people with heart failure. He also provides support for the National Cardiovascular Prevention Programme.
He has been involved in the establishment and subsequent development of the community-based Gloucestershire Heart Failure Service since its inception in 2003 where he continues to work as a GPSI.
Maggie Simpson is Cardiology Advanced Nurse Practitioner in NHS Greater Glasgow and Clyde and a third-year medical student at the University of Edinburgh. Maggie is a member of the Board of the European Society of Cardiology Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions, for which she is Chair of the education committee. She is also Chair of the British Adult Congenital Cardiac Nurse Association and the Scottish Heart Failure Nurse Forum. Maggie is also a member of the British Society for Heart Failure education committee. Maggie led the women’s heart health subgroup of the Scottish Government’s ‘Women’s Health Plan’ and continues to contribute to implementing the Plan’s actions.
Her areas of interest include adult congenital heart disease; cardiac obstetrics; chronic, acute and advanced heart failure; devices; biomarkers; valvular heart disease and women’s heart health.
Rhys Williams is a highly specialised clinical pharmacist, practising as an independent prescriber within cardiology. Rhys has a keen interest in the management and practice-based research of heart failure and promoting the benefits and role of a specialist pharmacist as part of the wider multi-disciplinary team. Rhys’ career ambition is to become a consultant pharmacist, where he can use his expert clinical knowledge to provide the highest quality of clinical care, influence national service provision and guidelines, and provide inspiration to the next generation of pharmacists.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email [email protected] or call 01276 698370.
425347 | June 2024
The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2024 Oxbridge Solutions Ltd®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions Ltd® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.
You will be directed to: https://www.health.novartis.co.uk/medicines/cardio-metabolic/entresto
Are you a UK healthcare professional?
The information is intended for UK healthcare professionals only.
Please confirm below.